ESC 365 - Why and how should we use 3D echo in: cancer patients treated with potentially cardiotoxic drugs?

EACVI Premium Access

Why and how should we use 3D echo in: cancer patients treated with potentially cardiotoxic drugs?

Session: Clinical use of 3D echo to assess ventricular geometry and function

Topic: The imaging examination and quality assessment

Speaker: Professor M. Monaghan (London, GB)

Event: EuroEcho-Imaging 2017

Congress Presentation

Add to my library

About the speaker

Professor Mark John Monaghan

King's College Hospital, London (United Kingdom of Great Britain & Northern Ireland)

15 presentations

1 follower

3 more presentations in this session

Why and how should we use 3D echo in: right heart disease.

Speaker: Doctor J. Morales Portano (Mexico City, MX)

Why and how should we use 3D echo in: heart failure?

Speaker: Doctor S. Kapetanakis (London, GB)

Why and how should we use 3D echo in: heart valve diseases?

Speaker: Assistant Professor N. Ajmone Marsan (Leiden, NL)

Access the full session

Clinical use of 3D echo to assess ventricular geometry and function

Speakers: Professor M. Monaghan, Doctor J. Morales Portano, Doctor S. Kapetanakis, Assistant Professor N. Ajmone Marsan

About the event

EuroEcho-Imaging 2017

6 December - 9 December 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources